3NUM is the world's first Web3 powered telephony protocol, bridging 5 billion mobile subscribers into secure communications with its innovative Web3 mobile number, known as the 3NUM Shield. The platform offers end-to-end encrypted voice and messaging services, allowing users to connect with existing phone contacts while maintaining privacy and security. With features like no SIM swaps and anonymous mobile numbers, 3NUM differentiates itself in the market by providing a decentralized communication solution that supports crypto payments and protects against spam and phishing. The company is set to launch full end-to-end encrypted services in 2025, positioning itself as a leader in the emerging Web3 communication space.

Agnostic is a blockchain data cloud platform that offers an open-source suite for indexing EVM blockchain data. It provides cost-effective solutions for analytics and API development, enabling users to build applications faster and more efficiently. With features like interactive analytics, optimized indexing, and customizable ETL pipelines, Agnostic differentiates itself by reducing infrastructure costs and development time significantly. The platform supports all major EVM blockchains and is designed for enterprises needing tailored data solutions, making it a strong player in the blockchain data market.

Airtm is a digital wallet that connects users to over 500 payment methods, allowing them to send, receive, and convert funds globally. The platform is designed to help individuals, especially in developing countries, manage their finances securely and efficiently, leveraging a peer-to-peer network for instant transactions. With a strong focus on user experience, Airtm offers a unique solution for freelancers, microtaskers, and gamers to generate income online while ensuring their funds are protected and easily accessible. The company has completed over 26 million transactions across 190 countries, positioning itself as a leader in the digital finance space.

Any Signal provides end-to-end RF solutions for advanced aircraft, satellites, and national security, focusing on communications, radar, navigation, and RF sensing. Founded in 2022, the company aims to redefine RF capabilities by offering innovative, cost-effective solutions that integrate hardware, software modems, and supporting software for data management and telemetry. Their products are designed for the most demanding missions, addressing the shortcomings of existing solutions in terms of cost and innovation. With a commitment to harnessing cutting-edge technologies, Any Signal is positioned to lead in military and commercial RF applications.

Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.

Biomia is a synthetic biology company that engineers nature-inspired small molecule therapeutics to address the global crisis of CNS disorders. Utilizing a proprietary platform that combines AI-driven discovery with yeast-based biomanufacturing, Biomia optimizes and scales novel drug candidates for conditions such as chronic pain, schizophrenia, and opioid use disorder. The company is positioned to lead in the development of safe and effective CNS therapeutics, with a strong pipeline of compounds and a proven team of industry professionals. Their innovative approach aims to overcome the limitations of current therapeutics, which often leave symptoms untreated and can lead to severe side effects.

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey.

Castelion Corporation is a defense tech company focused on modern defense production, specializing in the rapid development and mass production of next-generation military systems. The company aims to maintain a global technical edge for the U.S. and its allies by providing affordable, high-performance systems designed for mass production. Their services include hypersonic testing, vehicle sub-systems, and strike systems, all developed with a focus on low-cost and high-cadence testing. With a strong leadership team from SpaceX and significant industry experience, Castelion is positioned to address critical national security challenges effectively.

Centrifuge is the platform for tokenized real-world assets onchain.

Chemify is a deep tech chemical science company that integrates chemistry, robotics, and AI to digitally design, discover, and manufacture new molecules. Their innovative approach, termed 'Chemputation', allows for the rapid and efficient design and synthesis of novel small molecules, particularly in drug discovery for diseases like tuberculosis and malaria. With significant backing, including a grant from the Bill & Melinda Gates Foundation, Chemify is positioned to scale its operations and expand into U.S. markets, making it a key player in the digitization of chemistry for pharmaceutical and industrial applications.

Clock Bio is a biotech company focused on extending human healthspan by developing innovative treatments that prevent and treat age-related diseases. Utilizing human pluripotent stem cells, Clock Bio has created a unique aging model that allows for the identification of gene candidates relevant to cellular rejuvenation through unbiased CRISPR screens. Their technology aims to decode rejuvenation biology comprehensively, positioning them as a leader in the regenerative medicine space with a strong focus on clinical applications and a roadmap for future growth.

Corintis offers a game-changing solution to the cooling of next-generation high-performance GPUs, CPUs, and AI accelerators. It is developing silicon microfluidic cooling technologies that enable liquid coolant to flow in direct contact with the silicon chip.